In a wide-ranging interview, Xavier Becerra, President Biden’s health secretary, defended his tenure and hinted that he might ...
Under President Joe Biden, enrollment in Medicaid hit a record high and the uninsured rate reached a record low. Donald Trump’s return to the White House — along with ...
U.S. stocks closed out Joe Biden’s era on a high note as the president bids farewell to the White House.
Dan Tsai discusses how he ran Medicaid under Biden, and his fears for how Republicans might try to change the program.
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
Private equity sponsors and their healthcare portfolio companies are expected to ride the tailwind of an M&A rebound. Long-term capital gains ...
Ozempic was one of the 15 drugs selected for the 2027 Medicare drug price negotiation program three days before ...
The U.S. Centers for Medicare and Medicaid Services released its list of drugs covered under Medicare Part D selected for the ...
A group of Republican attorneys general have lost their bid for a temporary injunction that would have blocked the federal ...
The US plans to slash the price it pays for the Novo Nordisk A/S blockbusters Ozempic and Wegovy, the latest drugs to be ...
The US plans to slash the price it pays for the Novo Nordisk A/S blockbusters Ozempic and Wegovy, the latest drugs to be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback